Review: AI evidence in CNS autoimmune disease is uneven

A new review assessed AI across multiple sclerosis, neuromyelitis optica spectrum disorder, autoimmune encephalitis and MOG antibody disease, covering automated imaging, differential diagnosis, relapse prediction and prognosis. Evidence is strongest in multiple sclerosis neuroimaging, and the authors say further validation is needed elsewhere.